Background & Aims Studies reporting that budesonide is effective for the treatment of
collagenous colitis have been small and differed in efficacy measures. Mesalamine has …

Background: Collagenous colitis is typified by chronic watery diarrhoea and characteristic
histological alterations of the colonic mucosa without endoscopic abnormalities …

Objective This 1-year study aimed to assess low-dose budesonide therapy for maintenance
of clinical remission in patients with collagenous colitis. Design A prospective, randomised …

Summary Background: Budesonide (Entocort) is effective for the treatment of collagenous
colitis. Aim: To assess the long‐term outcome of patients after induction of clinical remission …

BACKGROUND & AIMS: Oral budesonide effectively induces clinical remission in patients
with collagenous colitis, a debilitating illness characterized by chronic watery/loose diarrhea …

Objective: To evaluate the efficacy and safety of long-term budesonide therapy for the
maintenance of clinical remission in patients with collagenous colitis. Design: Randomised …

BACKGROUND & AIMS:: Collagenous colitis (CC) is a well-described entity causing chronic
diarrhea and characteristic histologic findings. Several treatment options have been …

Background: Collagenous colitis is characterised by diarrhoea, lymphocytic inflammation,
and a thickened subepithelial collagen layer in the colorectal mucosa. No standard …

Background Oral budesonide has been proven effective in short-and long-term treatment of
collagenous colitis; however, symptom relapse frequently occurs after drug withdrawal. The …

OBJECTIVES: Collagenous colitis is a chronic watery diarrhea disorder characterized by a
subepithelial collagen layer and a lymphoplasmacytic infiltration within the lamina propria …